| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/08/2004 | CN1165328C New prepn process of Lideri ganula as one traditional Mongoliam medicine |
| 09/08/2004 | CN1165326C New prepn process of Zhuanglong granula as one traditional Mongolian medicine |
| 09/08/2004 | CN1165325C New prepn process of Manu as one traditional Mongolian medicine |
| 09/08/2004 | CN1165321C Recipe and prepn process of spleen and kidney invigorating medicine |
| 09/08/2004 | CN1165315C Remedies for joint diseases |
| 09/08/2004 | CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450 |
| 09/08/2004 | CN1165308C Compositions and method for reducing respiratory depression and attendant side effect of mu opioid compounds |
| 09/08/2004 | CN1165293C New oral formulation for 5-HT4 agonists or antagonists |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787650 Ccr5 antagonistic activity; such as n-(3-(4-benzyl-1-piperidinyl)propyl)-n'-4-chlorophenyl)-n-phenylurea |
| 09/07/2004 | US6787563 Antidiarrhea agents; gastrointestinal disorders |
| 09/07/2004 | US6787562 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 09/07/2004 | US6787560 Serotonin reuptake inhibitor |
| 09/07/2004 | US6787559 Sulfonamide compounds |
| 09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 09/07/2004 | US6787556 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787552 PPAR delta activators |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787548 Cardiovascular insufficiency and erectile dysfunction; 3-(4-(3-chloro-4-hydroxybenzylamino) benzo(4,5)thieno(2,3-d)pyrimidin-2-yl)propionic acid |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787541 Thieno-and furopyrimidine derivatives as A2A-receptor antagonists |
| 09/07/2004 | US6787536 Hydroxamic acid derivatives |
| 09/07/2004 | US6787535 Indole derivatives with 5HT6 receptor affinity |
| 09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
| 09/07/2004 | US6787521 Skin disorders; kidney and liver disorders |
| 09/07/2004 | US6787355 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
| 09/07/2004 | US6787342 Paste formulations |
| 09/07/2004 | US6787319 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 09/07/2004 | US6787317 Method of identifying missing domains in receptors |
| 09/07/2004 | US6787134 Methods for preventing/remedying mastitis |
| 09/07/2004 | CA2166898C Novel structural analogues of vitamin d |
| 09/07/2004 | CA2093770C Aspartic acid derivatives, their preparation and use |
| 09/02/2004 | WO2004074484A1 Method of screening apoptosis-controlling agent |
| 09/02/2004 | WO2004074319A1 Physiologically active peptides and drugs containing the same |
| 09/02/2004 | WO2004074297A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators |
| 09/02/2004 | WO2004074295A1 Thiazole cycle polymers, process for producing the same, synthesis intermediates thereof and utilization of the same |
| 09/02/2004 | WO2004074277A1 N-aryl- or n-heteroarylpiperazine derivative and medicine containing the same |
| 09/02/2004 | WO2004074260A1 Pyrimidine derivatives |
| 09/02/2004 | WO2004074258A1 Novel sulphated imidazole derivatives, method for production thereof, novel intermediates obtained, application thereof as medicaments and pharmaceutical compositions comprising the above |
| 09/02/2004 | WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids |
| 09/02/2004 | WO2004074240A1 Prostaglandin derivatives |
| 09/02/2004 | WO2004074238A1 Phenethylamino sulfamic acids |
| 09/02/2004 | WO2004073749A1 Dispersant for sustained release preparations |
| 09/02/2004 | WO2004073741A1 Remedy for spinal injury containing interleukin-6 antagonist |
| 09/02/2004 | WO2004073740A1 Regulator of interstitial angiotensin ii hyperproduction and preventive or remedy for the onset of arteriosclerosis, heart and brain vascular diseases and/or diabetic complications |
| 09/02/2004 | WO2004073733A1 Interleukin 6 production inhibitor |
| 09/02/2004 | WO2004073727A1 Method for improving qol and composition therefor |
| 09/02/2004 | WO2004073723A1 Medical drug containing fine particle of noble metal |
| 09/02/2004 | WO2004073722A1 Superoxide anion decomposing agent |
| 09/02/2004 | WO2004073718A1 Therapeutic agent for hemorrhoidal disease |
| 09/02/2004 | WO2004073717A1 Blood-vessel-growth promoter |
| 09/02/2004 | WO2004073706A1 Drug for reducing side effects in ribavirin interferon combination therapy |
| 09/02/2004 | WO2004073701A1 Lfa-1 inhibitors and use thereof |
| 09/02/2004 | WO2004037187A3 Metal-containing materials, compositions and methods |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | WO2003084344A3 Method of improving absorption of vitamin e by a pet animal |
| 09/02/2004 | WO2003049698A8 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 09/02/2004 | WO2003026617A8 (ester)-lysolecithins in liposomes |
| 09/02/2004 | WO2002074289A3 Antitumor compositions containing taxane derivatives |
| 09/02/2004 | US20040172687 Modified proteinase inhibitors |
| 09/02/2004 | US20040172665 Compositions and methods for treating enzyme deficiency |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171844 Dihydro-2H-naphthalene-1-one inhibitors of ras farnesyl transferase |
| 09/02/2004 | US20040171835 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 09/02/2004 | US20040171830 Carboline derivatives as pdev inhibitors |
| 09/02/2004 | US20040171828 Respiratory system disorders; asthma; antihistamines |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171793 Cyclic peptides as potent and selective melanocortin-4 receptors agonists |
| 09/02/2004 | US20040171690 Use of protein essential aminoacids to treat amenorrhea and related disorders |
| 09/02/2004 | US20040171681 Medicines and medicinal kits |
| 09/02/2004 | US20040171679 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 09/02/2004 | US20040171676 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 09/02/2004 | US20040171671 Cyclic ester of 3-hydroxybutyric acid; increasing cardiac efficiency, alternative glucose energy source, free radical scavenging |
| 09/02/2004 | US20040171669 Rapid disintegration on contact with saliva forming easy to swallow palatable suspension; tablets |
| 09/02/2004 | US20040171660 Single dose aromatase inhibitor for treating infertility |
| 09/02/2004 | US20040171658 Blood coagulation factor Xa inhibition; such as 2-O-(3'-amidinobenzyl)-5-O-(3''-amidinophenyl)-1,4:3,6-dianhydrosorbitol |
| 09/02/2004 | US20040171646 Novel substituted benzimidazole dosage forms and method of using same |
| 09/02/2004 | US20040171645 Treating extrapyramidal movement disorder adverse effects of antiparkinson's drugs |
| 09/02/2004 | US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 09/02/2004 | US20040171639 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/02/2004 | US20040171637 anticancer agents; in admixture with one or more pharmaceutically acceptable carriers or diluents and a known chemotherapeutic agent |
| 09/02/2004 | US20040171623 thieno[2,3-d]pyrimidinediones; modulation of autoimmune disease |
| 09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
| 09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
| 09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
| 09/02/2004 | US20040171607 Chemical compounds |
| 09/02/2004 | US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/02/2004 | US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 09/02/2004 | US20040171592 reduced gastric effects; salicylic acid derivatives |
| 09/02/2004 | US20040171582 comprises a lysophosphatidic acid (LPA) receptor modulator; EDG-2 agonist or antagonist |
| 09/02/2004 | US20040171555 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
| 09/02/2004 | US20040171546 Regulation of lung tissue by hedgehog-like polypeptides and formulations and uses related thereto |